CXCR4 and HIV infectious disease: Because none of the participants received antiretroviral therapy over the course of the study [12], this result can be interpreted as estimating the expected waiting time for the first CXCR4-using variants to emerge as a product of the accumulation of genetic variation in an HIV infection in the absence of antiretroviral selection.